Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
Launched by SAN DIEGO STATE UNIVERSITY · Jul 9, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how young adults with type 2 diabetes can use a device called a continuous glucose monitor (CGM) to better manage their blood sugar levels. The CGM is a small sensor that tracks glucose (sugar) in the body throughout the day and night, giving users real-time information about their blood sugar patterns. The study will provide these devices to participants for 30 days to see how easy they are to use, what helps or makes it harder for people to use them, and how using the CGM might change their awareness of their blood sugar levels.
To take part, people need to be between 18 and 45 years old, have been diagnosed with type 2 diabetes within the last five years, and have never used a CGM before. Participants also need a smartphone that works with the Dexcom CGM app and be comfortable using it in English or Spanish. People who are pregnant, recently had a baby, or have serious mental health conditions won’t be able to join. During the study, participants will wear the CGM for a month and share their experiences to help researchers understand how this technology might support better diabetes self-care in young adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult 18-45 years of age
- • diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
- • no prior use or experience with wearable CGMs
- • possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
- • fluency in English or Spanish
- Exclusion Criteria:
- • severe mental illness (e.g., psychosis, suicidal ideation);
- • pregnancy or \<6 months postpartum
About San Diego State University
San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Jessica L McCurley, PhD MPH
Principal Investigator
San Diego State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported